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TelemedicineAbstract Objective: To compare agreement and reliability between clinician-measured and
patient self-measured clinical and functional assessments for use in remote monitoring, in a
home-based setting, using telehealth.
Design: Reliability study: repeated-measure, within-subject design.
Setting: Trained clinicians measured standard clinical and functional parameters at a face-to-
face clinic appointment. Participants were instructed on how to perform the measures at home
and to repeat self-assessments within 1 week.
Participants: Liver transplant recipients (LTRs) (NZ18) (5214y, 56% men, 5.44.3y posttrans-
plant] completed the home self-assessments.
Interventions: Not applicable.
Main Outcome Measures: The outcomes assessed were body weight, systolic and diastolic
blood pressure (SBP and DBP), waist circumference, repeated chair sit-to-stand (STST),
maximal push-ups, and the 6-minute walk test (6MWT). Intertester reliability and agreement
between face-to-face clinician and self-reported home-based participant measures were
determined by intraclass-correlation coefficients (ICCs) and Bland-Altman plots, which were
compared with minimal clinically important differences (MCID) (determined a priori).
Results: The mean difference (95% confidence interval) and [limits of agreement] for measures
(where positive values indicate lower participant value) were weight, 0.7 (0.01-1.4) kg [2.2
to 3.6kg]; waist 0.4 (1.2 to 2.0) cm [5.9 to 6.8cm]; SBP 7.7 (0.6-14.7 ) mmHg [19.4 to
34.9mmHg]; DBP 2.4 (1.4 to 6.2 ) mmHg [12.2 to 17.0mmHg]; 6MWT, 7.5 (29.1 to
44.1) m [127.3 to 142.4m]; STST 0.5 (0.8 to 1.7) seconds [4.3 to 5.3s]; maximal push-
ups 2.2 (4.4 to 0.1) [10.5 to 6.0]. ICCs were all >0.75 except for STST (ICCZ0.73). Mean
differences indicated good agreement than MCIDs; however, wide limits of agreement indi-
cated large individual variability in agreement.
Conclusions: Overall, LTRs can reliably self-assess clinical and functional measures at home.
However, there was wide individual variability in accuracy and agreement, with no functional
assessment being performed within acceptable limits relative to MCIDs >80% of the time.
ª 2020 The Authors. Published by Elsevier Inc. on behalf of the American Congress of Rehabil-
itation Medicine. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).The use of telehealth strategies for chronic disease
management favors equitable access to health services for
patients across wide geographical dispersion, increases
patient’s self-care management, and reduces the patient’s
time away from daily life as well as travel costs.1 Although a
variety of telehealth strategies have been used successfully
to deliver lifestyle interventions for weight reduction and
improvements in metabolic risk factors,2,3 their translation
into clinical practice is complex due to the need to monitor
outcomes remotely.
Effectiveness of telehealth exercise interventions
often rely on monitoring change in functional tests such as
the 6-minute walk test (6MWT) and the repeated sit-to-
stand test (STST). These measures have shown good validity
and patient acceptability when conducted by health care
professionals.4,5 However, these clinical studies have
generally required participants to return to the clinical
center for repeat testing or outcome assessment and
therefore do not overcome the burden of face-to-face
attendance at the health care facility. Limited data are
available on the agreement and reliability of home-based
self-assessment of common clinical outcome measures
such as waist circumference6-8 and blood pressure.9-11
This study aimed to determine the level of agreement
and reliability of clinician-measured versus participantself-measured (ie, in an unsupervised, home-based setting)
clinical and functional assessments commonly used for
monitoring effectiveness of telehealth-delivered lifestyle
interventions in liver transplant recipients (LTRs). This pa-
tient cohort has previously indicated a preference and
motivation for flexible access to health care options
including telehealth monitoring.12 We hypothesized that
LTRs would reliably self-assess clinical and functional out-
comes with an acceptable level of agreement (ie, partici-
pant measures would be below a predetermined minimal
clinically important difference at least 80% of the time for
each outcome measure).Materials and methods
This is a substudy from a larger randomized controlled
feasibility study (35 participants randomized, with 27
participants completing the study) investigating telehealth-
to-home delivered lifestyle intervention to enhance
cardiometabolic health (ACTRN12617001260314). The study
conformed to the ethical guidelines of the 1975 Declaration
of Helsinki and was approved by the Metro South Human
Research Ethics Committee (HREC/17/QPAH/208).
Clinician vs patient assessment reliability 3Participants were recruited from August to December
2017. Participants were adults (aged 18-70) under the care
of the Queensland Liver Transplant Service, >6 months
posttransplant, expected survival>1 year, living within 100
km of the hospital (primary care center). Participants were
required to have current access to a mobile phone or
computer hardware with internet access and capabilities
for webcam attachment. Volunteers were excluded if they
reported having a dietary restriction that would make the
dietary component of the parent study inappropriate, had a
physical disability that would impair participation in
physical activity, were deemed unsafe to participate in a
lifestyle intervention by a hepatologist or transplant
surgeon, or did not have sufficient English literacy. All
participants provided written informed consent prior to
participation.Procedure
Trained health professionals (exercise physiologists [nZ2]
and dietitians [nZ4]) performed clinical and functional
assessments at a baseline face-to-face clinic appointment.
Baseline study appointments were attended for the purpose
of research and not due to clinical follow-up. Assessments
were performed by different health professionals from the
multidisciplinary research team to replicate a real-world
clinical setting. Participants were directed to undertake
self-measured clinical and functional assessments at home,
unsupervised, within 1 week of baseline clinic assessment.
The 1-week timeframe was designed to minimize the effect
of time on differences in repeat measures. Participants
were instructed on how to perform each assessment at
home and were provided with written instructions and links
to video-recorded tutorials to view online. Equipment for
participants to conduct all functional measures and waist
circumference at home were provided (listed below).
Results were recorded and sent to investigators via email,
or verbally transcribed at the next telehealth appointment.
Participants received up to 3 phone call reminders to
complete the assessments. The clinician-measured face-to-
face assessments were compared with the patient-at-home
(unsupervised) assessments to determine agreement and
reliability.
Outcome measures were chosen to reflect the pragmatic
needs of real-world clinical telehealth practice where
reliable, accessible, inexpensive measures of metabolic risk
need to be longitudinally monitored to assess the effec-
tiveness of telehealth-delivered lifestyle interventions.Clinical measures
Body mass
Clinician-assessed body weight was recorded to the nearest
0.5 kg (Robusta 813a). Participants used their own personal
scales to record weight (various brands, not recorded).Waist circumference
Clinician-assessed waist circumference was measured
midway between the lower rib margin and iliac crest with
stomach muscles relaxed, to the nearest 1 cm. Identical
tape measures were provided to all participants for the
repeat home measure with written and pictorial in-
structions to take the measure at the same site.
Blood pressure
Clinician-assessed systolic and diastolic blood pressure (SBP
and DBP) were performed seated using Welch Allyn Cerner
Vital Signs Monitorb with an appropriate size cuff. An
average of 3 measures was taken to the nearest 1 mmHg.
Participants were instructed to either use home blood
pressure machines or attend a local pharmacy to have
blood pressure performed by a pharmacist (various brands,
not recorded). Home- or pharmacy-based blood pressure
was taken twice on the same arm, with at least 1 minute
between readings after sitting quietly for a minimum of 5
minutes. If a >5 mmHg difference between the first and
second readings was observed, a third measure was taken.
Participants reported all BP results and investigators
calculated the average. Participants were instructed to




The 6MWT was conducted on a 10-m track within an indoor
corridor after a standardized protocol.13 A premeasured
piece of string marked the 10-m track and turn around
points. The trained clinician used a lap counter to count the
number of laps that the participant completed within 6
minutes and calculated the number of meters walked to the
nearest 10 m. Participants practiced using the lap counter
during the baseline test and were provided with the string,
lap counter, and stopwatch for home testing.
Repeated STST
The repeated STST provides a measure of functional leg
power and strength and was conducted according to a
standardized protocol.13 The test required a straight-back
armless chair of standard height (42cm, recommended for
both clinic- and home-based measures) placed firmly
against a wall. After performing an initial single chair stand
with arms folded across the chest and feet flat on the floor,
the time to complete 5 repeat chair stands was recorded in
seconds. A stopwatch was provided to participants who
used a suitable chair in their home for all home-based tests.
Maximal push-up test
The maximal push-up test is a measure of upper body
strength and endurance. For men, the test was conducted
in the full push-up position (hands a comfortable distance
apart, back straight, and using the toes as the pivot point)
and for women the test was conducted in the modified







Age (y) 51.713.9 49.715.6 .7
Sex (n)
Women 8 2 .03*
Men 10 15
BMI (kg/m2) 27.57.7 27.45.2 >.99
Weight (kg) 78.620.3 87.717.5 .17
Waist circumference (cm) 9615 10116 .35
SBP (mmHg) 13717 13217 .42
DBP (mmHg) 849 819 .43
6MWT (m)y 46680 47193 .87
STST (s)z 10 (8-16) 12 (9-16) .04*
Push-ups (n)z 86 1011 .48
NOTE. Data are presented as means  SD or medians (range, min to max). All data presented are assessments completed by the clinician
at the baseline face-to-face appointment. An independent sample t test was used to compare the 2 groups.
Abbreviation: BMI, body mass index.
* P<.05.
y nZ16 completers and nZ19 noncompleters.
z nZ17 completers and nZ18 noncompleters.
4 S.E. Keating et al.push-up posture (as per men, but with the lower legs
together in contact with the ground and ankles plantar
flexed), according to a standardized protocol.13 A marker
(standard sized can of food) was placed on its end below
the head of the participant to mark the range of motion
required for each push-up. Prior to the test, participants
completed up to 3 repetitions to ensure correct technique
and then rested for 1 minute before completing the test.
Participants then completed the maximum number of push-
ups possible with good technique, consecutively without
rest. Participants were given an exercise matc and
instructed to use a can of equal size to complete their
home-based test.
Statistical analysis
Data analyses was performed using SPSS 25.d Data were
verified for normal distribution via the Shapiro-Wilks test,
the Kolmogorov-Smirnov test, and visualization of Q-Q
plots. Patient characteristic data were compared between
those who did and did not complete the home assessments
using an independent t test (numerical data) or chi-square
test (categorical data). A 1-sample t test was conducted to
determine whether there were statistically significant
differences between the clinician-measured assessments
and participant home assessment for each clinical and
functional test variable, with a test value of 0. Agreement
between clinician and study participant assessments was
determined according to Bland-Altman plots. The Bland-
Altman plots show mean difference and limits of agree-
ment between the 2 methods, with limits of agreement
calculated as mean difference  1.96 standard deviation.
Bland-Altman analyses are reported as mean difference
(95% confidence interval) and limits of agreement (lower
limit of agreement [LoA]-upper LoA). The mean difference
was calculated as clinician measurement minus participant
measurement, and thus a positive mean differenceindicated that the participant-measured value was lower
than the clinician-measured value. Systematic bias was
assessed by the 1-sample t test to determine if the mean
difference was significantly different from 0 and/or if the
line of equality (yZ0) was outside the 95% confidence in-
terval of the mean difference. Proportional bias was
assessed by linear regression to determine whether the
average of the measures (independent variable) was
significantly related to the difference between the clinician
and participant measures (dependent variable).
The extent to which measurements can be replicated
between the clinician and the participant was further
assessed via intraclass correlation coefficients (ICCs) using
a 2-way mixed model with absolute agreement. ICCs were
interpreted as poor (<0.5), moderate (0.5-0.74), good
(0.75-0.9), and excellent (>0.9).14 With 2 observations per
participant (ie, the clinician assessment and the participant
assessment), a minimum sample size of nZ13 would be
required to achieve the statistical significance, based on
ICCs of 0.70, for an alpha value set at 0.05 and a minimum
power of 90%.15
Determining clinically meaningful agreement
In addition to the statistical approaches, minimal clinically
important differences (MCIDs) were used to interpret the
level of clinically meaningful reliability and agreement for
each assessment. Differences between clinician-measured
and participant-measured scores below the MCID were
judged as representing an acceptable level of agreement.
As recommended by Revicki et al,16 multiple methods
(anchor and distribution methods) were used to determine
the MCID for each measure, in particular where existing
literature was sparse. Accordingly, for this study, a clini-
cally meaningful agreement (ie, a difference lower than
the a priori MCID) for each variable was defined as a dif-
ference less than weight 3%, waist 2%, SBP 10 mmHg,




























/2 SD: <0.75 kg
EM: <0.07 kg
3% 16/18 (89)












/2 SD: <1.6 cm
EM: <0.33 cm
2% 12/18 (67)














10 mmHg 11/17 (65)




DBP should be retested if
readings differ
>6mmHg.13
/2 SD: 3.7 mmHg
EM: <2.65 mmHg
5 mmHg 8/17 (47)




MCIDZ1.7 s in patients
with COPD.21
MCIDZ2.5 s (95% LoA Z
2.6 to 2.6s) in older
female adults.22
/2 SD: <1.2 s
EM: <1.24 s
£1.5 s 6/17 (35)




MCIDZ36 m in patients
with chronic heart
failure.23
MCIDZ43.1 (16.8) m and
95% CI, 31.8-54.4 m in
patients with chronic
heart failure.24
MCIDZ25 m in patients
with coronary artery
disease.25
/2 SD: < 34.45 m
EM: <17.7 m
30 m 6/16 (38)









































































































































































































































































































































































































































































6 S.E. Keating et al.DBP 5 mmHg, 6MWT 30 m, push-ups 2, and STST
1.5 seconds. An outcome measure was considered
acceptable overall if the limits of agreement fell below
the predetermined MCID. A self-assessed unsupervised
outcome measure was also deemed acceptable overall if
study participants were within the limits of clinically
meaningful agreement at least 80% of the time.Results
Thirty-five participants (71% men, mean age:
50.714.6y, mean body mass index: 27.46.5kg/m2)
were recruited to the parent study, with all participants
consenting to undertake the repeated home measures.
Of the 35 participants who had baseline face-to-face
clinical and functional assessments with the clinician,
18 (51%) performed repeat baseline self-assessments at
home. The mean time between clinician measures and
participant home retest assessments was 12.69.5 days.
There were no significant differences in baseline char-
acteristics and physical function for those who did and
did not complete self-assessments at home, except for
sex and STST. A greater proportion of women completed
the home retest than men (80% vs 40%; PZ.03). Higher
STST completion time, indicating reduced function, was
recorded in those completing home tests than those
who did not (10s [8-16s] vs 12s [9-16s]; PZ.04) (table 1).
Reliability for assessments between clinician and
participant measurement was excellent for weight and
waist circumference (ICC>0.9), good for DBP
(ICCZ0.87) and SBP (ICCZ0.77) (table 2). There were
no differences between the mean clinician-measured
scores and mean participant-measured scores for
weight (PZ.59), waist (PZ.56), and DBP (PZ.20);
however, SBP was significantly lower (PZ.04) for the
participant-measured score than that of the clinician.
For all clinical outcomes, participants measured lower
scores for their clinical measures on average when
compared with clinician-measured values (see table 2).
Moreover, the limits of agreement for all clinical mea-
sures fell outside the MCID, demonstrating wide indi-
vidual variability for self-assessed reliability (figs 1A-D).
SBP demonstrated the greatest variability (lower LoA
(19.35 mmHg) and upper LoA [34.58 mmHg]) with wide
95% confidence intervals for interrater reliability
(ICCZ0.35-0.92) indicating large variability (see
table 2) (fig 1C). Bland-Altman analysis also demon-
strated systematic bias for SBP whereby participant
measures were systematically lower than clinician
measures (7.7mmHg [0.6-14.7]; PZ.04). Linear regres-
sion of the Bland-Altman analysis showed proportional
bias in DBP (rZ0.56, PZ.02) whereby the higher the
DBP reading, the poorer the agreement in the measures
between the clinician and the participant. No other
proportional bias was observed (rZ0.31, rZ0.30,
rZ0.23, P>.05 for weight, waist, and SBP, respectively).
Weight was the only clinical measure that was measured
by the participant within the acceptable level of
agreement at least 80% of the time (89%, 16/18 partic-
ipants) (see table 2 and fig 1A).
Fig 1 Bland-Altman plots of the difference between face-to-face clinician-measured and participant self-assessments performed
at home versus the mean of clinician-measured and participant-measured assessments for (A) weight, nZ18; (B) waist, nZ18; (C)
SBP, nZ17; and (D) DBP, nZ17. Solid line indicates the mean difference, and dashed lines indicate the upper and lower limits of
agreement. Shaded regions represent the clinically acceptable limits of agreement.
Clinician vs patient assessment reliability 7Reliability for assessments between clinician- and
participant-measured 6MWT and push-ups were excellent
(ICC>0.9) and good for STST (ICCZ0.73) with wide 95%
confidence intervals indicating large variability (see
table 2). There were no significant differences between the
mean clinician-measured scores and the mean participant-
measured scores for 6MWT or STST (P>.05); however, the
mean number of push-ups measured by participants wasFig 2 Bland-Altman plots of the difference between face-to-face
at home versus the mean of clinician-measured and participant-me
(C) push-up test nZ17. Solid line indicates the mean difference, a
ment. Shaded regions represent the clinically acceptable limits ofsystematically higher than that measured by clinicians
(2.2 [4.4, e0.1]; PZ.04). On average, participants
measured lower distances for their 6MWT and STST (see
table 2). The limits of agreement for all functional tests fell
outside the MCID (figs 2A-C), demonstrating high individual
variability in agreement for each functional measure, with
the 6MWT demonstrating the greatest variability (lower LoA
to upper LoA: 127.3 to 142.4m) (see fig 2A). Linearclinician-measured and participant self-assessments performed
asured assessments for (A) 6MWT, nZ16; (B) STST, nZ17; and
nd dashed lines indicate the upper and lower limits of agree-
agreement.
8 S.E. Keating et al.regression of the Bland-Altman analysis did not find
proportional bias in any functional test (rZ0.27, rZ0.38,
rZ0.10, P>.05, for 6MWT, STST, push-up test, respec-
tively). No functional test was determined to be
acceptable; that is, none were conducted with 80% of
participants’ scores within the MCID (see table 2).Discussion
This study evaluated the level of agreement and reliability
of participant-measured home-based (unsupervised)
assessments for use as outcome measures for remote
monitoring in telehealth lifestyle interventions. We
employed a multipronged approach to establish test-retest
reliability (using ICCs), levels of agreement (using Bland-
Altman plots and 1-sample t test), and whether participants
were able to measure clinical and functional outcomes
within a clinically acceptable range (based on MCID
determined via distribution and anchoring methods).
Generally, based on ICCs and mean differences, the reli-
ability between assessments performed by participants and
clinicians was moderate to excellent; however, there was
notable between-individual variability with wide limits of
agreement. Bland-Altman plots define the limits of agree-
ment but do not determine whether these limits are
acceptable or not for the clinical purpose of the measure.29
Therefore, limits of acceptability were determined a priori
based on MCIDs that were derived from clinically and
analytically relevant criteria. The self-assessments were
further explored by comparing the limits of agreement of
each measure with the MCID and the percentage of par-
ticipants whose self-assessment measures were within the
acceptable range.
Contrary to our hypothesis, despite the moderate to
excellent intertester reliability, all limits of agreement
were outside of the clinically acceptable range. Only body
weight was retested by participants within clinically
acceptable limits of agreement >80% of the time. Overall,
the mean differences between clinician- and patient-
measured outcomes seemed acceptable. However, for
some participants, there were clinically significant differ-
ences between the results obtained by clinicians and
participants that could affect clinical decision making for
that participant. It is important to be attentive to the
effect of this variability when making clinical decisions
using outcomes obtained by patients. Our findings highlight
the need for significant methodological consideration
regarding the selection and implementation of appropriate,
feasible, and reliable outcome measures for self-
assessment in telehealth-to-home interventions and
training of assessors.
Accurate and reliable blood pressure monitoring is
notoriously difficult in both clinical and community
settings,30,31 and this study reinforces the numerous
barriers to remote blood pressure monitoring including
access to robust home BP monitoring equipment, biological
variability, and patients understanding of, and compliance
with, strict pretest criteria and instructions. Although SBP
had the lowest intertester reliability with a significant
difference between the average clinician- and participant-
measured scores, clinician-measured blood pressure hasalso been to shown to be problematic.32,33 Although
clinician-measured cuff BP is the reference standard for
managing high BP, it is widely acknowledged that it is not a
criterion standard measure31,32 and may be affected
by circadian variability and white coat effects. Although
24-hour ambulatory monitoring is accepted as the criterion
standard for clinical judgement regarding BP,31 it is unlikely
feasible for pragmatic study designs in large clinical studies
or real-world practice. To reduce variability in home-based
BP measures, researchers and clinicians should ensure
standardization of methods (eg, measures taken at the
same time of day, at the same location, with the same
pretest instructions for known influences of BP including
caffeine and physical activity).
Body weight and waist circumference were conducted
with the highest level of agreement, which is consistent
with the literature.17 However, only body weight was
determined to be acceptable based on comparisons with
MCID. For the 6MWT, despite the high relative reliability
determined by ICCs, which is consistently reported in the
literature,34,35 the limits of agreement were broad. Thus,
although the 6MWT may demonstrate high statistical
intertester reliability, participants were only within
clincially acceptable agreement with clinician measures
38% of the time. Interestingly, a recent study by Hwang
et al36 examined the reliability of clinicians to measure
supervised face-to-face 6MWT assessment versus super-
vised telehealth 6MWT assessment and found that, although
ICCs were high (ICCZ0.90), the limits of agreement (84 to
76m) were above the predetermined clinically acceptable
range (36m) in patients with chronic heart failure.36 The
authors also observed that clinician test-retest measures
were outside the clinically acceptable range 29% of the
time. Together, our studies suggest that the high variability
in reliability of the 6MWT may not be limited to participant
skill alone. The source of variation in both clinic- and home-
based measurements may be influenced by numerous
factors including biological variation, measurement
variation, skill or technique, or psychological factors such
as motivation and self-efficacy. LTRs have a lifelong
relation with their specialist care center and have
expressed a desire for remote monitoring via telehealth
services.12 Thus, there is bidirectional motivation for cli-
nicians and patients to explore enablers and barriers to
reliable home self-assessments to monitor longitudinal
outcomes remotely from the clinic using telehealth-to-
home innovations. Although the 6MWT may be a prag-
matic choice of outcome for lifestyle interventions, there is
a need for more training and facilitation for patients to
improve self-assessment feasibility for telehealth use.
Although adding to resource burden, supervision of the
6MWT via telehealth may improve reliability.36 Promoting
to the patients the value of self-assessment and remote
monitoring of health outcomes may also facilitate improved
telehealth interactions between stakeholders.
Study limitations
Despite all necessary equipment and resources provided,
only half of the participants performed home assessments,
and the mean time difference between clinician assess-
ment and participant measures in those who did complete
Clinician vs patient assessment reliability 9the home assessments (129.5d) exceeded the requested
1-week timeframe. This indicates that there are additional
barriers to completing home self-assessment. Although it is
unlikely that any clinically relevant changes to outcomes
would have occurred in this timeframe, real-world clinical
feasibility is lowered, irrespective of the reliability of those
who did perform the measures. Patient activation and
engagement with remote monitoring technology is critical
and remains an ongoing challenge for telehealth monitoring
services. Further methodological strategies to enhance
compliance with self-assessment, as well as exploration of
barriers and enablers to self-assessment, are required to
increase the uptake of unsupervised home assessment
within telehealth interventions. Our interpretation of
agreement and reliability for all outcome measures was
also limited by the lack of evidence to inform MCID for
outcome measure, specifically in LTRs.
Finally, given the known sensitivity of blood pressure
measures to day-to-day environmental factors, participants
were asked to avoid caffeine, exercise, and smoking for 30
minutes prior to the measure and to sit quietly for 5 mi-
nutes prior to measures. However, because of the prag-
matic design of the study, we were unable to ensure that
participant blood pressure measures were undertaken at
the same time of day and were unable to detect possible
white coat effects. Identifying the source of variation for
each measure was beyond the scope of this study.
Conclusion
This study determined that overall, patient self-assessed
clinical and functional outcome measures for metabolic
health and fitness had good agreement and reliability on
average with face-to-face clinician-assessed outcome
measures in LTRs. However, at an individual level, there
was considerable variation. With the current methodolo-
gies, aside from body weight, no clinical or functional
outcome was deemed acceptable when compared
with MCIDs. Moreover, only 51% of LTRs in the study
undertook self-assessed measures at home. Clinicians
wishing to remotely monitor health outcomes from
lifestyle-based interventions in chronic disease via tele-
health may need to consider greater standardization, and
to provide training and facilitation to patients to improve
the uptake and reliability of patient home-based health
assessments.
Suppliers
a. Robusta 813; Seca.
b. Welch Allyn Cerner Vital Signs Monitor; Hillron.
c. Exercise mat; Kmart Australia Limited.
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